Skip to content
N1 Life
All Insights

Scientific Perspectives

A Vehicle Arm Is Not an Empty Baseline

A nonmedicated control group still uses a formulation, often alongside a skincare routine. The trial result cannot isolate the base alone.

  • formulation evidence
  • vehicle arm
  • dermatology trials

A control group is still using a formulation

In a dermatology trial, a vehicle is the base formulation without the active drug. It may contain emollients or humectants. Participants may also follow a cleansing, moisturizing, and sunscreen routine. A vehicle arm is therefore a useful comparison, but it is not an empty baseline. [1]

A 2026 review examined placebo-controlled dermatology trials. In two phase III acne trials involving 2,817 participants, facial inflammatory lesions fell by 44.8% and 51.2% in the vehicle groups. The corresponding reductions in the active-treatment groups were 54.4% and 66.2%. The active treatment performed better, while the control groups also changed substantially. [1]

What the numbers cannot separate

Those control-group outcomes do not measure the vehicle’s effect alone. The base formulation, the accompanying skincare routine, consistent use, and trial participation can all contribute. The review’s authors note that a no-intervention arm would be needed to isolate the vehicle’s specific contribution. [1]

For a topical development team, the practical question is what was actually tested. Was the active measured in its intended final formulation? Were the base, routine, and use conditions comparable between groups? A result from one vehicle cannot establish what a different finished formula will do in skin. The vehicle is part of the experiment; its contribution must be interpreted within that experiment.

Sources

  1. Siripanich C, Chow YC, Ali FR. Clinical implications of skincare: lessons from placebo-controlled dermatology trials. Skin Health and Disease. 2026;6(3):207–213.